|
CN110022881B
(zh)
|
2016-11-18 |
2023-05-02 |
艾库斯生物科学有限公司 |
Cd73介导的免疫抑制的抑制剂
|
|
AU2018235092B2
(en)
|
2017-03-16 |
2024-09-19 |
Innate Pharma |
Compositions and methods for treating cancer
|
|
US11129841B2
(en)
|
2017-05-10 |
2021-09-28 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
AU2018346447B2
(en)
|
2017-10-06 |
2025-06-19 |
Innate Pharma |
Restoration of T cell activity via the CD39/CD73 axis
|
|
US11377469B2
(en)
|
2017-11-03 |
2022-07-05 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
WO2019173682A1
(en)
|
2018-03-09 |
2019-09-12 |
Arcus Biosciences, Inc. |
Parenterally administered immune enhancing drugs
|
|
CA3098493A1
(en)
|
2018-04-30 |
2019-11-07 |
Oric Pharmaceuticals, Inc. |
Cd73 inhibitors
|
|
TW202017569A
(zh)
|
2018-05-31 |
2020-05-16 |
美商佩樂敦治療公司 |
用於抑制cd73之組合物及方法
|
|
TWI870353B
(zh)
|
2018-06-18 |
2025-01-21 |
法商天賜製藥公司 |
用於治療癌症之組合物及方法
|
|
CN112638389A
(zh)
*
|
2018-08-28 |
2021-04-09 |
江苏恒瑞医药股份有限公司 |
Cd73抑制剂及其治疗用途
|
|
MX2021002878A
(es)
*
|
2018-09-11 |
2021-08-16 |
Risen Suzhou Pharma Tech Co Ltd |
Inhibidores de cd73 y usos farmaceuticos de los mismos.
|
|
US11530234B2
(en)
|
2018-09-11 |
2022-12-20 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 inhibitors and pharmaceutical uses thereof
|
|
CN110885352B
(zh)
*
|
2018-09-11 |
2023-02-24 |
润佳（苏州）医药科技有限公司 |
Cd73抑制剂及其药学应用
|
|
US12673969B2
(en)
|
2018-09-11 |
2026-07-07 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 inhibitors and pharmaceutical uses thereof
|
|
WO2020146795A1
(en)
|
2019-01-11 |
2020-07-16 |
Omeros Corporation |
Methods and compositions for treating cancer
|
|
WO2020151707A1
(zh)
*
|
2019-01-22 |
2020-07-30 |
江苏恒瑞医药股份有限公司 |
一种新型的小分子cd73抑制剂、其制备方法及其在医药上的应用
|
|
ES3070946T3
(en)
*
|
2019-03-12 |
2026-06-18 |
Arcus Biosciences Inc |
Treatment of an oncogenene driven cancer having a kras or egfr mutation by decreasing adenosine production or antagonizing adenosine activation
|
|
CA3135487A1
(en)
|
2019-03-29 |
2020-10-08 |
Arcus Biosciences, Inc. |
Treatment of cancer utilizing an identified adenosine fingerprint
|
|
US12544391B2
(en)
|
2019-07-16 |
2026-02-10 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
CN116854758A
(zh)
|
2019-10-30 |
2023-10-10 |
欧瑞克制药公司 |
Cd73抑制剂
|
|
CA3173831A1
(en)
|
2020-03-19 |
2021-09-23 |
Arcus Biosciences, Inc. |
Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha
|
|
TW202210514A
(zh)
|
2020-06-02 |
2022-03-16 |
美商阿克思生物科學有限公司 |
針對tigit的抗體
|
|
CN116546990B
(zh)
*
|
2020-11-25 |
2026-05-26 |
润佳（苏州）医药科技有限公司 |
Cd73抑制剂及其药学应用
|
|
EP4341262A1
(en)
|
2021-05-21 |
2024-03-27 |
Arcus Biosciences, Inc. |
Axl inhibitor compounds
|
|
WO2022246177A1
(en)
|
2021-05-21 |
2022-11-24 |
Arcus Biosciences, Inc. |
Axl compounds
|
|
TW202325279A
(zh)
|
2021-10-29 |
2023-07-01 |
美商阿克思生物科學有限公司 |
HIF-2α抑制劑及其使用方法
|
|
AU2023252914A1
(en)
|
2022-04-13 |
2024-10-17 |
Arcus Biosciences, Inc. |
Combination therapy for treating trop-2 expressing cancers
|
|
CN119156228A
(zh)
|
2022-05-02 |
2024-12-17 |
艾库斯生物科学有限公司 |
抗tigit抗体及其用途
|
|
EP4541803A4
(en)
*
|
2022-06-17 |
2025-10-01 |
Shanghai Senhui Medicine Co Ltd |
CYCLOPENTYLADENOSINE DERIVATIVE AND ITS PHARMACEUTICAL USE
|
|
EP4554680A1
(en)
|
2022-07-15 |
2025-05-21 |
Arcus Biosciences, Inc. |
Inhibitors of hpk1 and methods of use thereof
|
|
WO2024020034A1
(en)
|
2022-07-20 |
2024-01-25 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
TW202421150A
(zh)
|
2022-09-14 |
2024-06-01 |
美商阿克思生物科學有限公司 |
艾魯美冷之分散體
|
|
EP4602041A1
(en)
|
2022-10-14 |
2025-08-20 |
Arcus Biosciences, Inc. |
Hpk1 inhibitors and methods of use thereof
|
|
EP4705292A1
(en)
|
2023-05-05 |
2026-03-11 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
CN116298323B
(zh)
*
|
2023-05-16 |
2023-08-22 |
南京联笃生物科技有限公司 |
一种用于诊断狼疮性肾炎的生物标志物及应用
|
|
WO2024243502A1
(en)
|
2023-05-25 |
2024-11-28 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
WO2025054339A1
(en)
|
2023-09-08 |
2025-03-13 |
Arcus Biosciences, Inc. |
Triazolopyridine compounds as inhibitors of kit
|
|
WO2025072330A1
(en)
|
2023-09-26 |
2025-04-03 |
Arcus Biosciences, Inc. |
Kit inhibitor compounds and methods of use thereof
|
|
EP4788432A1
(en)
|
2023-10-06 |
2026-08-12 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
US12384773B2
(en)
|
2023-11-02 |
2025-08-12 |
Arcus Biosciences, Inc. |
Thiazole compounds and methods of use thereof
|
|
WO2025119278A1
(zh)
*
|
2023-12-07 |
2025-06-12 |
无锡和誉生物医药科技有限公司 |
一种cd73抑制剂药物组合物，其制备方法和应用
|
|
US20250230168A1
(en)
|
2023-12-22 |
2025-07-17 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025193759A1
(en)
|
2024-03-12 |
2025-09-18 |
Gilead Sciences, Inc. |
Solid forms of an azolopyrimidine compound
|
|
WO2025233264A1
(en)
|
2024-05-07 |
2025-11-13 |
Innate Pharma |
Use of cd73 blocking agents in combination with anti-cd20 x cd3 t cell engagers
|
|
WO2026006759A1
(en)
|
2024-06-28 |
2026-01-02 |
Arcus Biosciences, Inc. |
Pharmaceutical compositions, dosage forms, and methods of making and using same
|